# Construction Partners, Inc.: financial statements, quarterly ROAD · Nasdaq · CIK 1718227 · [Industrials](/sectors/industrials.md) · fiscal year ends Sep 30 Pages: [Overview](/companies/road.md) · [Financials](/companies/road/financials.md) · [Filings](/companies/road/filings.md) · [Insiders](/companies/road/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/road/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [475 d](/filings/0001628280-25-053871.md) | [397](/filings/0001718227-25-000020.md) | [371](/filings/0001718227-25-000063.md) | [518](/filings/0001718227-25-000081.md) | [538 d](/filings/0001628280-25-053871.md) | [562](/filings/0001628280-26-006228.md) | [572](/filings/0001628280-26-032643.md) | [779](/filings/0001628280-26-054661.md) | [900 d](/filings/0001628280-25-053871.md) | [809](/filings/0001628280-26-006228.md) | [769](/filings/0001628280-26-032643.md) | [999](/filings/0001628280-26-054661.md) | | Cost of revenue | $m | [399 d](/filings/0001628280-25-053871.md) | [345](/filings/0001718227-25-000020.md) | [333](/filings/0001718227-25-000063.md) | [434](/filings/0001718227-25-000081.md) | [454 d](/filings/0001628280-25-053871.md) | [485](/filings/0001628280-26-006228.md) | [500](/filings/0001628280-26-032643.md) | [647](/filings/0001628280-26-054661.md) | [740 d](/filings/0001628280-25-053871.md) | [688](/filings/0001628280-26-006228.md) | [670](/filings/0001628280-26-032643.md) | [831](/filings/0001628280-26-054661.md) | | Gross profit | $m | [75.5 d](/filings/0001628280-25-053871.md) | [51.9](/filings/0001718227-25-000020.md) | [38.8](/filings/0001718227-25-000063.md) | [83.5](/filings/0001718227-25-000081.md) | [84.1 d](/filings/0001628280-25-053871.md) | [76.6](/filings/0001628280-26-006228.md) | [71.4](/filings/0001628280-26-032643.md) | [132](/filings/0001628280-26-054661.md) | [159 d](/filings/0001628280-25-053871.md) | [122](/filings/0001628280-26-006228.md) | [98.9](/filings/0001628280-26-032643.md) | [168](/filings/0001628280-26-054661.md) | | Operating income | $m | [44.8 d](/filings/0001628280-25-053871.md) | [16.7](/filings/0001718227-25-000020.md) | [3.1](/filings/0001718227-25-000063.md) | [45.7](/filings/0001718227-25-000081.md) | [45.8 d](/filings/0001628280-25-053871.md) | [13.8](/filings/0001628280-26-006228.md) | [27.3](/filings/0001628280-26-032643.md) | [82.9](/filings/0001628280-26-054661.md) | [101 d](/filings/0001628280-25-053871.md) | [50.4](/filings/0001628280-26-006228.md) | [37.4](/filings/0001628280-26-032643.md) | [109](/filings/0001628280-26-054661.md) | | Interest expense | $m | not reported | [3.7](/filings/0001718227-25-000020.md) | [4.6](/filings/0001718227-25-000063.md) | [4.7](/filings/0001718227-25-000081.md) | [6.1 d](/filings/0001628280-25-053871.md) | [18.1](/filings/0001628280-26-006228.md) | [21.6](/filings/0001628280-26-032643.md) | [25.2](/filings/0001628280-26-054661.md) | [25.4 d](/filings/0001628280-25-053871.md) | [27.4](/filings/0001628280-26-006228.md) | [25.6](/filings/0001628280-26-032643.md) | [30.3](/filings/0001628280-26-054661.md) | | Income tax | $m | [10.3 d](/filings/0001628280-25-053871.md) | [3.1](/filings/0001718227-25-000020.md) | [(0.3)](/filings/0001718227-25-000063.md) | [10.1](/filings/0001718227-25-000081.md) | [10.3 d](/filings/0001628280-25-053871.md) | [(0.8)](/filings/0001628280-26-006228.md) | [1.3](/filings/0001628280-26-032643.md) | [13.9](/filings/0001628280-26-054661.md) | [18.4 d](/filings/0001628280-25-053871.md) | [5.6](/filings/0001628280-26-006228.md) | [2.9](/filings/0001628280-26-032643.md) | [19.6](/filings/0001628280-26-054661.md) | | Net income | $m | [30.9 d](/filings/0001628280-25-053871.md) | [9.8](/filings/0001718227-25-000081.md) | [(1.1)](/filings/0001718227-25-000081.md) | [30.9](/filings/0001718227-25-000081.md) | [29.3 d](/filings/0001628280-25-053871.md) | [(3.1)](/filings/0001628280-26-054661.md) | [4.2](/filings/0001628280-26-054661.md) | [44.0](/filings/0001628280-26-054661.md) | [56.6 d](/filings/0001628280-25-053871.md) | [17.2](/filings/0001628280-26-054661.md) | [9.2](/filings/0001628280-26-054661.md) | [59.6](/filings/0001628280-26-054661.md) | | Diluted EPS | $ per share | not reported | [0.19](/filings/0001718227-25-000020.md) | [(0.02)](/filings/0001718227-25-000063.md) | [0.59](/filings/0001718227-25-000081.md) | not reported | [(0.06)](/filings/0001628280-26-006228.md) | [0.08](/filings/0001628280-26-032643.md) | [0.79](/filings/0001628280-26-054661.md) | not reported | [0.31](/filings/0001628280-26-006228.md) | [0.16](/filings/0001628280-26-032643.md) | [1.06](/filings/0001628280-26-054661.md) | | Basic EPS | $ per share | not reported | [0.19](/filings/0001718227-25-000020.md) | [(0.02)](/filings/0001718227-25-000063.md) | [0.60](/filings/0001718227-25-000081.md) | not reported | [(0.06)](/filings/0001628280-26-006228.md) | [0.08](/filings/0001628280-26-032643.md) | [0.80](/filings/0001628280-26-054661.md) | not reported | [0.31](/filings/0001628280-26-006228.md) | [0.16](/filings/0001628280-26-032643.md) | [1.07](/filings/0001628280-26-054661.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [48.2](/filings/0001718227-24-000102.md) | [68.7](/filings/0001718227-24-000012.md) | [48.0](/filings/0001718227-24-000029.md) | [56.3](/filings/0001718227-24-000061.md) | [74.7](/filings/0001628280-25-053871.md) | [133](/filings/0001718227-25-000020.md) | [102](/filings/0001718227-25-000063.md) | [114](/filings/0001718227-25-000081.md) | [156](/filings/0001628280-26-054661.md) | [104](/filings/0001628280-26-006228.md) | [76.9](/filings/0001628280-26-032643.md) | [94.5](/filings/0001628280-26-054661.md) | | Current assets | $m | [473](/filings/0001718227-24-000102.md) | [461](/filings/0001718227-24-000012.md) | [475](/filings/0001718227-24-000029.md) | [554](/filings/0001718227-24-000061.md) | [585](/filings/0001628280-25-053871.md) | [723](/filings/0001718227-25-000020.md) | [730](/filings/0001718227-25-000063.md) | [809](/filings/0001718227-25-000081.md) | [935](/filings/0001628280-26-054661.md) | [809](/filings/0001628280-26-006228.md) | [862](/filings/0001628280-26-032643.md) | [961](/filings/0001628280-26-054661.md) | | Total assets | $m | [1,220](/filings/0001718227-24-000102.md) | [1,276](/filings/0001718227-24-000012.md) | [1,313](/filings/0001718227-24-000029.md) | [1,432](/filings/0001718227-24-000061.md) | [1,542](/filings/0001628280-25-053871.md) | [2,568](/filings/0001718227-25-000020.md) | [2,754](/filings/0001718227-25-000063.md) | [2,926](/filings/0001718227-25-000081.md) | [3,239](/filings/0001628280-26-054661.md) | [3,359](/filings/0001628280-26-006228.md) | [3,439](/filings/0001628280-26-032643.md) | [3,612](/filings/0001628280-26-054661.md) | | Current liabilities | $m | [279](/filings/0001718227-24-000102.md) | [263](/filings/0001718227-24-000012.md) | [290](/filings/0001718227-24-000029.md) | [346](/filings/0001718227-24-000061.md) | [380](/filings/0001628280-25-053871.md) | [470](/filings/0001718227-25-000020.md) | [514](/filings/0001718227-25-000063.md) | [552](/filings/0001718227-25-000081.md) | [582](/filings/0001628280-26-054661.md) | [508](/filings/0001628280-26-006228.md) | [564](/filings/0001628280-26-032643.md) | [614](/filings/0001628280-26-054661.md) | | Total liabilities | $m | [703](/filings/0001718227-24-000102.md) | [755](/filings/0001718227-24-000012.md) | [788](/filings/0001718227-24-000029.md) | [879](/filings/0001718227-24-000061.md) | [968](/filings/0001628280-25-053871.md) | [1,757](/filings/0001718227-25-000020.md) | [1,946](/filings/0001718227-25-000063.md) | [2,073](/filings/0001718227-25-000081.md) | [2,327](/filings/0001628280-26-054661.md) | [2,389](/filings/0001628280-26-006228.md) | [2,459](/filings/0001628280-26-032643.md) | [2,571](/filings/0001628280-26-054661.md) | | Long-term debt | $m | [361](/filings/0001718227-24-000102.md) | [427](/filings/0001718227-24-000012.md) | [423](/filings/0001718227-24-000029.md) | [454](/filings/0001718227-24-000061.md) | [487](/filings/0001628280-25-053871.md) | [1,183](/filings/0001718227-25-000020.md) | [1,319](/filings/0001718227-25-000063.md) | [1,393](/filings/0001718227-25-000081.md) | [1,574](/filings/0001628280-26-054661.md) | [1,705](/filings/0001628280-26-006228.md) | [1,711](/filings/0001628280-26-032643.md) | [1,745](/filings/0001628280-26-054661.md) | | Current portion of debt | $m | [15.0](/filings/0001718227-24-000102.md) | [15.0](/filings/0001718227-24-000012.md) | [15.0](/filings/0001718227-24-000029.md) | [23.9](/filings/0001718227-24-000061.md) | [26.6](/filings/0001628280-25-053871.md) | [37.7](/filings/0001718227-25-000020.md) | [40.4](/filings/0001718227-25-000063.md) | [38.5](/filings/0001718227-25-000081.md) | [38.5](/filings/0001628280-26-054661.md) | [38.5](/filings/0001628280-26-006228.md) | [38.5](/filings/0001628280-26-032643.md) | [41.5](/filings/0001628280-26-054661.md) | | Shareholders' equity | $m | [517](/filings/0001628280-25-053871.md) | [521](/filings/0001718227-25-000081.md) | [525](/filings/0001718227-25-000081.md) | [553](/filings/0001718227-25-000081.md) | [574](/filings/0001628280-26-054661.md) | [811](/filings/0001628280-26-054661.md) | [808](/filings/0001628280-26-054661.md) | [853](/filings/0001628280-26-054661.md) | [912](/filings/0001628280-26-054661.md) | [969](/filings/0001628280-26-054661.md) | [979](/filings/0001628280-26-054661.md) | [1,041](/filings/0001628280-26-054661.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [62.6 d](/filings/0001628280-25-053871.md) | [60.4](/filings/0001718227-25-000020.md) | [18.2 d](/filings/0001718227-25-000063.md) | [34.6 d](/filings/0001718227-25-000081.md) | [95.9 d](/filings/0001628280-25-053871.md) | [40.7](/filings/0001628280-26-006228.md) | [55.6 d](/filings/0001628280-26-032643.md) | [83.0 d](/filings/0001628280-26-054661.md) | [112 d](/filings/0001628280-25-053871.md) | [82.6](/filings/0001628280-26-006228.md) | [65.2 d](/filings/0001628280-26-032643.md) | [93.1 d](/filings/0001628280-26-054661.md) | | Capital expenditure | $m | [18.8 d](/filings/0001628280-25-053871.md) | [26.8](/filings/0001718227-25-000020.md) | [28.7 d](/filings/0001718227-25-000063.md) | [14.9 d](/filings/0001718227-25-000081.md) | [17.5 d](/filings/0001628280-25-053871.md) | [26.8](/filings/0001628280-26-006228.md) | [41.4 d](/filings/0001628280-26-032643.md) | [36.7 d](/filings/0001628280-26-054661.md) | [33.0 d](/filings/0001628280-25-053871.md) | [35.5](/filings/0001628280-26-006228.md) | [46.3 d](/filings/0001628280-26-032643.md) | [62.5 d](/filings/0001628280-26-054661.md) | | Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Share repurchases | $m | not reported | [1.3](/filings/0001718227-25-000020.md) | not reported | not reported | not reported | [12.1](/filings/0001628280-26-006228.md) | [8.0 d](/filings/0001628280-26-032643.md) | [0.7 d](/filings/0001628280-26-054661.md) | [2.7 d](/filings/0001628280-25-053871.md) | [22.4](/filings/0001628280-26-006228.md) | [3.5 d](/filings/0001628280-26-032643.md) | [3.8 d](/filings/0001628280-26-054661.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: not reported - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [52.1](/filings/0001718227-24-000012.md) | [51.8](/filings/0001718227-24-000029.md) | [52.3](/filings/0001718227-24-000061.md) | [52.4](/filings/0001718227-25-000020.md) | [51.9](/filings/0001718227-25-000063.md) | [52.7](/filings/0001718227-25-000081.md) | [54.2](/filings/0001628280-26-006228.md) | [55.7](/filings/0001628280-26-032643.md) | [55.7](/filings/0001628280-26-054661.md) | [56.0](/filings/0001628280-26-006228.md) | [56.3](/filings/0001628280-26-032643.md) | [56.3](/filings/0001628280-26-054661.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.